Biomerica, Inc. (NASDAQ:BMRA) Short Interest Update

Biomerica, Inc. (NASDAQ:BMRA) saw a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 49,700 shares, a decrease of 65.5% from the February 28th total of 143,900 shares. Based on an average daily volume of 7,100,000 shares, the short-interest ratio is presently 0.0 days. Approximately 0.3% of the company’s shares are short sold.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Biomerica stock. Granahan Investment Management LLC grew its stake in Biomerica, Inc. (NASDAQ:BMRA) by 24.9% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 658,767 shares of the company’s stock after buying an additional 131,306 shares during the quarter. Granahan Investment Management LLC owned 3.59% of Biomerica worth $198,000 as of its most recent filing with the SEC. Institutional investors own 22.28% of the company’s stock.

Biomerica Stock Performance

Shares of BMRA opened at $0.62 on Friday. The company’s 50-day simple moving average is $0.67 and its 200-day simple moving average is $0.45. Biomerica has a 1 year low of $0.24 and a 1 year high of $1.27. The stock has a market capitalization of $11.35 million, a PE ratio of -1.82 and a beta of -1.16.

Biomerica (NASDAQ:BMRA) last released its earnings results on Tuesday, January 14th. The company reported ($0.06) earnings per share (EPS) for the quarter. Biomerica had a negative return on equity of 90.19% and a negative net margin of 100.52%.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.